Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CBT · NYSE · Diversified Chemicals
Cabot Corp (CBT) · oqro.io/stocks/CBT · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$70.48−2.35 (−3.23%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
No open-market purchase by an insider of Cabot Corp was filed in the last 90 days. The latest on record was on Jun 1, 2018.
Since 2005, Cabot Corp insiders reported 1,123 open-market purchases and 348 sales on Forms 4 and 5, with purchases in 5 different years, most recently 2018.
In the last 90 days, 1 insider of Cabot Corp (CBT) reported 2 open-market sales worth $11.7M in total on SEC Form 4. The largest seller by value was Sean D Keohane, with $11.7M. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
No trade in Cabot Corp (CBT) was disclosed by a member of Congress in the last 12 months.
Cabot Corp's next results are expected on Feb 1, 2027. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
+20.0% (+$11.77) from Nov 20, 2025 to Nov 20, 2026 · adjusted daily closes
Adjusted close went from $58.71 on Nov 20, 2025 to $70.48 on Nov 20, 2026 (+20.0%). Disclosed in this range: 3 insider trades, 0 pre-arranged insider sales, 0 Congress trades, and 13 13F position changes for 4 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Diversified Chemicals company based in Boston, Massachusetts.
Last 12 months
+20.1%
Market value
$3.74B
S&P 500 +5.7% over the same dates. Prices adjusted for splits and dividends.
Short interest: 5.2M shares sold short (9.8% of shares outstanding), +5.7% vs the previous count, 13.8 days of normal trading to buy them back. FINRA, as of Oct 30, 2026. Short interest history
Revenue, fiscal 2026
$3.74B
+0.8% vs the year before
Net income, fiscal 2026
$213M
As reported in the annual filing
Shares outstanding
51.4M
As of Nov 16, 2026
In fiscal 2026 the company spent $146M buying back its own shares and $97M on dividends. Cash actually paid, from its cash-flow statement.
Next ex-dividend date Nov 27, 2026: $0.4725 a share (quarterly), payable Dec 11, 2026. Calendar
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Insider selling
14 days before an 8-KTraded Aug 28 · filed 3 days laterNot reported under a pre-arranged trading plan
Since the trade −15.7% · S&P 500 −10.3% · to Nov 20
The CEO of Cabot sold $11.5M of Cabot shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Aug 24 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −16.0% · S&P 500 −9.7% · to Nov 20
The CEO of Cabot sold $238K of Cabot shares. The filing does not indicate a pre-arranged trading plan.
Fund moves
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
10 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 13, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Against the S&P 500 over the year
Since Nov 19, 2025, CBT is up 17.9% and the index fund is up 4.1%: 14 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much CBT moves
Beta 0.5 (1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).
Top officer leaving
“Keohane of Cabot Corporation (the “Company”) notified the Company’s Board of Directors (the “Board”) of his decision to retire as President and Chief Executive Officer and resign as a Director of the Company and a member of the Board’s Executive Committee, each effective September 30, 2026.”
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
Insiders of Cabot Corp reported 1,123 open-market purchases and 348 sales since 2005; purchases in 5 different years, most recently 2018.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $19.6M3×3 trades |
| 2025 | — | $9.07M4×4 trades |
| 2024 | — | $26.3M38×38 trades |
| 2023 | — | $9.29M6×6 trades |
| 2022 | — | $5.85M13×13 trades |
| 2021 | — | $1.63M5×5 trades |
| 2019 | — | $194K2×2 trades |
| 2018 | $124K1×1 trade | $29.8M22×22 trades |
| 2017 | — | $25.7M20×20 trades |
| 2016 | — | $18.7M20×20 trades |
| 2015 | — | $2.05M5×5 trades |
| 2014 | — | $13.5M17×17 trades |
| 2013 | — | $10.5M14×14 trades |
| 2012 | — | $10M11×11 trades |
| 2011 | — | $1.51M3×3 trades |
| 2010 | — | $2.14M6×6 trades |
| 2009 | $189K2×2 trades | $61.2M5×5 trades |
| 2008 | $11.2M415×415 trades | $9.78M7×7 trades |
| 2007 | $27.3M512×512 trades | $8.61M97×97 trades |
| 2006 | $45.2M193×193 trades | $5.53M48×48 trades |
| 2005 | — | $137K2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
Funds and stakes
Contracts, lobbying and filings
Company reports, price and press
Revenue
$1.01B
+12.2% vs the same quarter a year earlier
Free cash flow, last 12 months
$214M
This quarter $88M, a year earlier $155M
Net debt
$902M
Debt $1.16B, cash $254M, at Sep 30, 2026
Net income, last 12 months
$213M
Operating profit covers interest 6.36x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Nov 2, 2026.
Revenue and earnings history, 19 fiscal yearsEarnings dates and the stock's moves
Who holds it
Attention
Things to keep in mind
People read Cabot Corp's Wikipedia article about 33 times a day over the last week, close to the 38 on a usual day of the three months before.
May 15, 2026Busiest day: 94 views on Jun 8, 2026Nov 20, 2026
Views of the article Cabot Corporation, by people (Wikimedia leaves out known bots). More readers means more attention, from news, results or anything else; it does not say anyone bought or sold. Source: Wikimedia pageviews.
2 certified in FY2026 Q3, vs 0 a year earlier. 2 positions in total, median offered wage $129K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Off-exchange trading: 39.5% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (26.9% on ATS, 12.6% with other brokers), close to its 26-week average of 38.9%. Weeks of Sep 21 to Oct 16, 2026.
Largest ATS: UBS ATS (15.2%), SIGMA X2 (12.1%), INTELLIGENT CROSS LLC (9.6%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.
Latest annual report filed Nov 20, 2026, compared with the one filed Nov 24, 2025. Read the filing
All 22 risk factor headings match the year before, give or take wording.
Cabot is a party in various lawsuits and environmental proceedings wherein substantial amounts are claimed. Additional information regarding legal proceedings involving Cabot is disclosed in Note R in Item 8 below, under the heading “Contingencies”, which disclosure is incorporated herein by reference.
The company describes its cases in the notes to its financial statements, in the same filing.
Source: SEC EDGAR, Form 10-K filed Nov 20, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
Fiscal year Oct 1, 2025 to Sep 30, 2026, from the annual report filed Nov 20, 2026. Read the filing
−1.9% on the year before ($2.34B)
+5.5% on the year before ($1.25B)
The segments reach the total once $128M of items outside them is counted: corporate items, and the removal of sales between segments so they are not counted twice, as the company reports them.
−2.5% on the year before ($2.11B)
+9.2% on the year before ($931M)
−0.4% on the year before ($670M)
The company also reports Asia Pacific ($1.47B), Americas ($1.29B), Europe, Middle East and Africa ($849M), which group lines above and are not added again.
Every annual report has a section where the company's managers explain the year's results (Item 7, Management's discussion and analysis). In this report it runs to about 6,000 words.
During fiscal 2026, Income (loss) from operations before income taxes and equity in earnings of affiliated companies decreased compared to fiscal 2025. The decrease was primarily due to lower Segment EBIT in our Reinforcement Materials segment, higher expenses related to restructuring activities, and a settlement charge for the termination of two pension plans in the U.K., partially offset by higher segment EBIT in our Performance Chemicals segment.
Source: SEC EDGAR, Form 10-K filed Nov 20, 2026. Revenue lines are the figures the company tags in its filing; OQRO shows a split only when its lines add up to the reported total revenue. The quote is the opening of the managers' discussion, cut at a sentence; the word count is estimated from its length. Not investment advice.
And 19 more headings in the filing.
Last results
Nov 2, 2026
Within the 30 days after it, until Dec 2, 2026
Next results, expected
Feb 1, 2027
Purchases after results
Not enough history
From Cabot Corp's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Cabot Corp's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.